aortic valve stenosis
Conditions
Interventions
to implement respiratory function test
Sponsors
Sakakibara heart Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients undergoing TAVI(with out tracheal intubation) from June 2017 to March 2019 at Sakakibara Heart Institute
Exclusion criteria
Exclusion criteria: informed consent was not obtained, emergent TAVI, ventilated, NYHA4, administerd inotropic agents, registered to other trial, difficult to undergoing respiratory function test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| respiratory function from postoperative day to one week after TAVI | — |
Countries
Japan
Contacts
Public ContactYuko Furuichi
Sakakibara heart Institute Dept of Anesthesiology
Outcome results
None listed